National Cancer Institute

New Screening Test Esoguard Offers Hope for Early Detection of Esophageal Cancer

Learn about Esoguard, a new screening test in Long Beach, California, offering hope for early detection of precancerous issues related to chronic heartburn. Find out how this miniature capsule is revolutionizing the screening process for esophageal cancer, a condition that can often go undiagnosed until it’s too late.

Washington University School of Medicine Joins National Clinical Trials Network for Cancer Screening

Washington University School of Medicine in St. Louis has joined a new national clinical trials network launched by the National Cancer Institute (NCI) to investigate emerging technologies for cancer screening. The goal of the network is to reduce cancer-related illnesses and deaths, with a key priority being the inclusion of participants from diverse populations. Collaborating with Siteman Cancer Center, the investigators will lead trials in Missouri and parts of Illinois, aiming to reach diverse populations, including those living in underserved areas. The network’s primary focus is to evaluate the effectiveness of a screening technology designed to detect multiple cancers with a single blood test, with the researchers aiming to determine whether such tests can detect cancer early and ultimately save lives.